425 related articles for article (PubMed ID: 27124606)
1. Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial.
Panahi Y; Kianpour P; Mohtashami R; Jafari R; Simental-Mendía LE; Sahebkar A
J Cardiovasc Pharmacol; 2016 Sep; 68(3):223-9. PubMed ID: 27124606
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial.
Panahi Y; Kianpour P; Mohtashami R; Jafari R; Simental-Mendía LE; Sahebkar A
Drug Res (Stuttg); 2017 Apr; 67(4):244-251. PubMed ID: 28158893
[TBL] [Abstract][Full Text] [Related]
3. Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults.
Zheng X; Gong L; Luo R; Chen H; Peng B; Ren W; Wang Y
Lipids Health Dis; 2017 Oct; 16(1):202. PubMed ID: 29037239
[TBL] [Abstract][Full Text] [Related]
4. Effect of Phytosomal Curcumin on Circulating Levels of Adiponectin and Leptin in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Mirhafez SR; Farimani AR; Dehhabe M; Bidkhori M; Hariri M; Ghouchani BF; Abdollahi F
J Gastrointestin Liver Dis; 2019 Jun; 28():183-189. PubMed ID: 31204416
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial.
Rahmani S; Asgary S; Askari G; Keshvari M; Hatamipour M; Feizi A; Sahebkar A
Phytother Res; 2016 Sep; 30(9):1540-8. PubMed ID: 27270872
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
[TBL] [Abstract][Full Text] [Related]
7. The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease.
Saadati S; Hatami B; Yari Z; Shahrbaf MA; Eghtesad S; Mansour A; Poustchi H; Hedayati M; Aghajanpoor-Pasha M; Sadeghi A; Hekmatdoost A
Eur J Clin Nutr; 2019 Mar; 73(3):441-449. PubMed ID: 30610213
[TBL] [Abstract][Full Text] [Related]
8. Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial.
Panahi Y; Khalili N; Sahebi E; Namazi S; Reiner Ž; Majeed M; Sahebkar A
Complement Ther Med; 2017 Aug; 33():1-5. PubMed ID: 28735818
[TBL] [Abstract][Full Text] [Related]
9. Serum Lipid Abnormalities and Nonalcoholic Fatty Liver Disease in Adult Males.
Peng K; Mo Z; Tian G
Am J Med Sci; 2017 Mar; 353(3):236-241. PubMed ID: 28262209
[TBL] [Abstract][Full Text] [Related]
10. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
Daneshi-Maskooni M; Keshavarz SA; Mansouri S; Qorbani M; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
Trials; 2017 Jun; 18(1):260. PubMed ID: 28592311
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol.
Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
BMJ Open; 2017 Jul; 7(7):e016914. PubMed ID: 28698350
[TBL] [Abstract][Full Text] [Related]
12. Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial.
Mohammadi A; Sahebkar A; Iranshahi M; Amini M; Khojasteh R; Ghayour-Mobarhan M; Ferns GA
Phytother Res; 2013 Mar; 27(3):374-9. PubMed ID: 22610853
[TBL] [Abstract][Full Text] [Related]
13. Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD).
Fernández Rodríguez CM; Aller R; Gutiérrez García ML; Ampuero J; Gómez-Camarero J; Martín-Mateos RMª; Burgos-Santamaría D; Rosales JM; Aspichueta P; Buque X; Latorre M; Andrade RJ; Hernández-Guerra M; Romero-Gómez M
Rev Esp Enferm Dig; 2019 Apr; 111(4):264-269. PubMed ID: 30810330
[TBL] [Abstract][Full Text] [Related]
14. Is There a Role for Curcumin Supplementation in the Treatment of Non-Alcoholic Fatty Liver Disease? The Data Suggest Yes.
Zabihi NA; Pirro M; Johnston TP; Sahebkar A
Curr Pharm Des; 2017; 23(7):969-982. PubMed ID: 27748192
[TBL] [Abstract][Full Text] [Related]
15. The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Jalali M; Mahmoodi M; Mosallanezhad Z; Jalali R; Imanieh MH; Moosavian SP
Complement Ther Med; 2020 Jan; 48():102283. PubMed ID: 31987259
[TBL] [Abstract][Full Text] [Related]
16. Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial.
Panahi Y; Valizadegan G; Ahamdi N; Ganjali S; Majeed M; Sahebkar A
J Cell Biochem; 2019 Sep; 120(9):15989-15996. PubMed ID: 31168845
[TBL] [Abstract][Full Text] [Related]
17. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
[TBL] [Abstract][Full Text] [Related]
18. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of curcumin plus piperine co-supplementation in moderate-to-high hepatic steatosis: A double-blind, randomized, placebo-controlled clinical trial.
Sharifi S; Bagherniya M; Khoram Z; Ebrahimi Varzaneh A; Atkin SL; Jamialahmadi T; Sahebkar A; Askari G
Phytother Res; 2023 Jun; 37(6):2217-2229. PubMed ID: 36799355
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between serum uric acid and risk of new-onset nonalcoholic fatty liver disease: a 5-year observational cohort study].
Bai JX; Shu RM; Huang Y; Peng Z
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):271-275. PubMed ID: 29996338
[No Abstract] [Full Text] [Related]
[Next] [New Search]
